295 related articles for article (PubMed ID: 21453880)
1. A randomised double-blind placebo-controlled trial with Lactobacillus acidophilus La-5 and Bifidobacterium animalis subsp. lactis BB-12 for maintenance of remission in ulcerative colitis.
Wildt S; Nordgaard I; Hansen U; Brockmann E; Rumessen JJ
J Crohns Colitis; 2011 Apr; 5(2):115-21. PubMed ID: 21453880
[TBL] [Abstract][Full Text] [Related]
2. Probiotic treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial with Lactobacillus acidophilus and Bifidobacterium animalis subsp. Lactis.
Wildt S; Munck LK; Vinter-Jensen L; Hanse BF; Nordgaard-Lassen I; Christensen S; Avnstroem S; Rasmussen SN; Rumessen JJ
Inflamm Bowel Dis; 2006 May; 12(5):395-401. PubMed ID: 16670529
[TBL] [Abstract][Full Text] [Related]
3. Impact of Bifidobacterium animalis subsp. lactis BB-12 and, Lactobacillus acidophilus LA-5-containing yoghurt, on fecal bacterial counts of healthy adults.
Savard P; Lamarche B; Paradis ME; Thiboutot H; Laurin É; Roy D
Int J Food Microbiol; 2011 Sep; 149(1):50-7. PubMed ID: 21296446
[TBL] [Abstract][Full Text] [Related]
4. Randomised placebo-controlled double blind multicentric trial on efficacy and safety of Lactobacillus acidophilus LA-5 and Bifidobacterium BB-12 for prevention of antibiotic-associated diarrhoea.
Chatterjee S; Kar P; Das T; Ray S; Gangulyt S; Rajendiran C; Mitra M
J Assoc Physicians India; 2013 Oct; 61(10):708-12. PubMed ID: 24772726
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Bifidobacterium breve Fermented Milk in Maintaining Remission of Ulcerative Colitis.
Matsuoka K; Uemura Y; Kanai T; Kunisaki R; Suzuki Y; Yokoyama K; Yoshimura N; Hibi T
Dig Dis Sci; 2018 Jul; 63(7):1910-1919. PubMed ID: 29450747
[TBL] [Abstract][Full Text] [Related]
6. Effects of synbiotic fermented milk containing Lactobacillus acidophilus La-5 and Bifidobacterium animalis ssp. lactis BB-12 on the fecal microbiota of adults with irritable bowel syndrome: A randomized double-blind, placebo-controlled trial.
Bogovič Matijašić B; Obermajer T; Lipoglavšek L; Sernel T; Locatelli I; Kos M; Šmid A; Rogelj I
J Dairy Sci; 2016 Jul; 99(7):5008-5021. PubMed ID: 27157575
[TBL] [Abstract][Full Text] [Related]
7. Probiotics for maintenance of remission in ulcerative colitis.
Iheozor-Ejiofor Z; Kaur L; Gordon M; Baines PA; Sinopoulou V; Akobeng AK
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD007443. PubMed ID: 32128794
[TBL] [Abstract][Full Text] [Related]
8. Probiotic Bifidobacterium lactis Probio-M8 treated and prevented acute RTI, reduced antibiotic use and hospital stay in hospitalized young children: a randomized, double-blind, placebo-controlled study.
Mageswary MU; Ang XY; Lee BK; Chung YF; Azhar SNA; Hamid IJA; Bakar HA; Roslan NS; Liu X; Kang X; Dai L; Sreenivasan S; Taib F; Zhang H; Liong MT
Eur J Nutr; 2022 Apr; 61(3):1679-1691. PubMed ID: 34825264
[TBL] [Abstract][Full Text] [Related]
9. Probiotic Yogurt Culture Bifidobacterium Animalis Subsp. Lactis BB-12 and Lactobacillus Acidophilus LA-5 Modulate the Cytokine Secretion by Peripheral Blood Mononuclear Cells from Patients with Ulcerative Colitis.
Sheikhi A; Shakerian M; Giti H; Baghaeifar M; Jafarzadeh A; Ghaed V; Heibor MR; Baharifar N; Dadafarin Z; Bashirpour G
Drug Res (Stuttg); 2016 Jun; 66(6):300-5. PubMed ID: 26909690
[TBL] [Abstract][Full Text] [Related]
10. Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis.
Venturi A; Gionchetti P; Rizzello F; Johansson R; Zucconi E; Brigidi P; Matteuzzi D; Campieri M
Aliment Pharmacol Ther; 1999 Aug; 13(8):1103-8. PubMed ID: 10468688
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of probiotic treatment with Bifidobacterium longum 536 for induction of remission in active ulcerative colitis: A randomized, double-blinded, placebo-controlled multicenter trial.
Tamaki H; Nakase H; Inoue S; Kawanami C; Itani T; Ohana M; Kusaka T; Uose S; Hisatsune H; Tojo M; Noda T; Arasawa S; Izuta M; Kubo A; Ogawa C; Matsunaka T; Shibatouge M
Dig Endosc; 2016 Jan; 28(1):67-74. PubMed ID: 26418574
[TBL] [Abstract][Full Text] [Related]
12. Probiotics for maintenance of remission in ulcerative colitis.
Naidoo K; Gordon M; Fagbemi AO; Thomas AG; Akobeng AK
Cochrane Database Syst Rev; 2011 Dec; (12):CD007443. PubMed ID: 22161412
[TBL] [Abstract][Full Text] [Related]
13. Effect of a Probiotic Supplement Containing Lactobacillus Acidophilus and Bifidobacterium Animalis Lactis on Urine Oxalate in Calcium Stone Formers with Hyperoxaluria: A Randomized, Placebo-controlled, Double-blind and In-vitro Trial.
Tavasoli S; Jalali S; Naji M; Borumandnia N; Shakiba Majd G; Basiri A; Khosravi Darani K; Karamad D; Tajabadi-Ebrahimi M; Taheri M
Urol J; 2021 Jun; 19(3):179-188. PubMed ID: 34129232
[TBL] [Abstract][Full Text] [Related]
14. Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial.
Feagan BG; Danese S; Loftus EV; Vermeire S; Schreiber S; Ritter T; Fogel R; Mehta R; Nijhawan S; Kempiński R; Filip R; Hospodarskyy I; Seidler U; Seibold F; Beales ILP; Kim HJ; McNally J; Yun C; Zhao S; Liu X; Hsueh CH; Tasset C; Besuyen R; Watanabe M; Sandborn WJ; Rogler G; Hibi T; Peyrin-Biroulet L
Lancet; 2021 Jun; 397(10292):2372-2384. PubMed ID: 34090625
[TBL] [Abstract][Full Text] [Related]
15. Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis.
Miele E; Pascarella F; Giannetti E; Quaglietta L; Baldassano RN; Staiano A
Am J Gastroenterol; 2009 Feb; 104(2):437-43. PubMed ID: 19174792
[TBL] [Abstract][Full Text] [Related]
16. Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study.
Vermeire S; Lakatos PL; Ritter T; Hanauer S; Bressler B; Khanna R; Isaacs K; Shah S; Kadva A; Tyrrell H; Oh YS; Tole S; Chai A; Pulley J; Eden C; Zhang W; Feagan BG;
Lancet Gastroenterol Hepatol; 2022 Jan; 7(1):28-37. PubMed ID: 34798037
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the immune benefits of two probiotic strains Bifidobacterium animalis ssp. lactis, BB-12® and Lactobacillus paracasei ssp. paracasei, L. casei 431® in an influenza vaccination model: a randomised, double-blind, placebo-controlled study.
Rizzardini G; Eskesen D; Calder PC; Capetti A; Jespersen L; Clerici M
Br J Nutr; 2012 Mar; 107(6):876-84. PubMed ID: 21899798
[TBL] [Abstract][Full Text] [Related]
18. Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial.
Peyrin-Biroulet L; Hart A; Bossuyt P; Long M; Allez M; Juillerat P; Armuzzi A; Loftus EV; Ostad-Saffari E; Scalori A; Oh YS; Tole S; Chai A; Pulley J; Lacey S; Sandborn WJ;
Lancet Gastroenterol Hepatol; 2022 Feb; 7(2):128-140. PubMed ID: 34798039
[TBL] [Abstract][Full Text] [Related]
19. Cobitolimod for moderate-to-severe, left-sided ulcerative colitis (CONDUCT): a phase 2b randomised, double-blind, placebo-controlled, dose-ranging induction trial.
Atreya R; Peyrin-Biroulet L; Klymenko A; Augustyn M; Bakulin I; Slankamenac D; Miheller P; Gasbarrini A; Hébuterne X; Arnesson K; Knittel T; Kowalski J; Neurath MF; Sandborn WJ; Reinisch W;
Lancet Gastroenterol Hepatol; 2020 Dec; 5(12):1063-1075. PubMed ID: 33031757
[TBL] [Abstract][Full Text] [Related]
20. Effect of the probiotic strain Bifidobacterium animalis subsp. lactis, BB-12®, on defecation frequency in healthy subjects with low defecation frequency and abdominal discomfort: a randomised, double-blind, placebo-controlled, parallel-group trial.
Eskesen D; Jespersen L; Michelsen B; Whorwell PJ; Müller-Lissner S; Morberg CM
Br J Nutr; 2015 Nov; 114(10):1638-46. PubMed ID: 26382580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
